AMAmit Mishra

Amit Mishra

*This is an algorithmically generated author record based on publicly available information.

Amit Mishra has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • pH-responsive silica nanocarriers of olaparib for augmenting anticancer activity: development, characterization, and in vitro cytotoxicity study against MCF-7 breast cancer cells

    by Ankita Gupta, Swatantra K. S. Kushwaha, Amit Mishra

    This study focuses on the development and assessment of innovative chitosan-grafted silica nanocarriers encapsulating the PARP inhibitor, olaparib, designed for targeted delivery in breast cancer cells. The formulation aims to enhance therapeutic precision and efficacy in cancer treatment. Silica nanocarriers (SNs) were synthesized through a sol–gel method and subsequently coated with chitosan, employing GPTMS as a coupling agent. Olaparib (Ola) was successfully incorporated into the chitosan grafted silica nanocarriers (Ola-Ch-SNs). The resulting nanocarriers were characterized using techniques such as XRD, TEM, DLS, and TGA–DSC. Drug release profiles were evaluated in PBS across different pH conditions, while cytotoxicity was measured using the SRB assay in MCF-7 breast cancer cells. Uniform, pH-sensitive olaparib-loaded chitosan-coated silica nanocarriers (Ola-Ch-SNs) were successfully synthesized and characterized using advanced techniques including SEM, TEM, TGA, DSC, and XRD. The nanocarriers demonstrated excellent stability, achieving a drug loading efficiency of 44.31 ± 0.21% and an encapsulation efficiency of 83.12 ± 0.08%. Distinct pH-responsive drug release behavior was observed, with cumulative olaparib release reaching 57.6 ± 0.34% at pH 4.0 and 47.3 ± 0.02% at pH 6.0 over 24 h, compared to 22.6 ± 0.14% at pH 7.4 over 72 h. Release kinetics, described by the Korsmeyer-Peppas model, indicated a mechanism driven by both diffusion and polymer relaxation. In vitro cytotoxicity assays on MCF-7 breast cancer cells revealed enhanced anticancer activity of Ola-Ch-SNs compared to free olaparib, achieving a GI₅₀ value below 10 µg/ml and reducing cell viability to 23.4 ± 0.3% at 80 µg/ml. These findings underscore the potential of Ola-Ch-SNs as an innovative, targeted drug delivery system for effective cancer therapy. We successfully developed pH-responsive chitosan-coated silica nanocarriers loaded with olaparib, showcasing remarkable cytotoxicity against breast cancer cells. This formulation holds promise for enhancing olaparib bioavailability and advancing targeted cancer therapies.


  • Open Access

    The Unexplained Negative Electromagnetic Radiation and its Reduction effect on Human by Electromagnetic seed Rudraksha

    by Subhashish Tripathy, Amit Mishra, Arun Kumar Mishra

    Electric and magnetic fields (EMFs) are indefinable regions of energy that are often referred to as Radiation and are linked to the use of electricity as well as various natural and man-made phenomena. Due to continuous exposure to Unexplained and negative EMF, people experienced stress, anxiety, Hypoxia, and even long-term exposure result in Cancer to patients. On the other hand, Rudraksha seeds are globally known as electromagnetic seeds due to their positive electromagnetic healing effect. This research was conducted to find the consequence of the Negative EMF effect on human pulse rate and Oxygen carrying capacity in blood and the use of Rudraksha to study cut off harmful effect of negative EMF by this Electromagnetic property. This topic constitutes a new domain with the largely unstudied potential of Rudraksha seeds shielding effect on Unexplained Negative Electromagnetic Radiation. Keywords: EMF, Rudraksha, electromagnetic seeds, human pulse rate, Oxygen carrying capacity, Negative Electromagnetic Radiation.


  • A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis

    by Ankita Gupta, Swatantra Singh Kushwaha, Amit Mishra

    Background: Cancer is a condition in which some cells in the body grow uncontrollably and can also spread in other parts of the body. Among males, oral and lung cancers account for 25 % cancer deaths, while in females, breast and oral cancers cause 25% death. Breast and cervical cancers are the underlying cause of the high mortality rate among women. Owing to limitations of conventional cancer therapy like low drug specificity, less solubility, multidrug resistance, poor access to tumor cells and low bioavailability development of environmentally sensitive and target specific nanocarriers are imperative. Objective: The objective of this study is to review advancements made in techniques to synthesize Mesoporous Silica Nanoparticles (MSN’s) as well as strategies to functionalize its silanol group for site-specific drug release in the tumor environment and to review recent patents published regarding it. To describe rationale for selection of MSN’s for cancer theranostics amidst other nanocarriers developed. Methods: In the first section of this review, the physical and chemical properties of MSNs making it an ideal delivery system for cancer therapy and diagnostics are discussed. In the next section, various techniques involved in synthesizing and loading MSNs, including the influence of basic components of MSNs and reaction conditions on its properties are reviewed. Then the wide application of MSNs and various exogenous and endogenous stimuli harnessed for site-specific delivery of cargo and recent patents on modifying environmental conditions for large scale synthesis of MSNs and its active targeting for cancer treatment and bioimaging are discussed. Results: Physico-chemical properties and synthetic protocols of MSNs justifying them to be a promising nanovector to overcome the ill effects of traditional chemotherapy. The superlative attributes of MSNs including, tunable size, morphology, high load volume, stability, ease of modifying external and internal surface leverage applications in various dimensions of therapeutics, diagnostics, and combinatorial drug delivery. MSNs surface functionalization can be harnessed for passive and active targeting by either coating the surface with polymers or attaching various ligands. Conclusion: An ideal nano-carrier must have high loading efficiency, easily detectable, and must have stimuli's sensitive, site-specific drug release. The patent study explores new dimensions on MSNs synthesis by claiming new cost-effective templates and silica source, a more safe environment for synthesis, reducing synthesis steps, duration of reaction, effective loading of low solubility drugs by magnetized nanocarriers, pathogen-specific release and development of novel photoluminescent rechargeable MSNs under mild conditions. It’s a challenging task for researchers to successfully translate their prototypes to industries and make it feasible for commercialization. We can further work on excellent targeting concepts and architecture of MSNs for the increased opportunity in cancer theranostics.


  • Physical Rheological and Cell Viability Study of Some Selected Plant Polysaccharides

    by Vikram Kumar Sahu, Amit Mishra, Nitin Sharma, Pratap Kumar Sahu, Shubhini A. Saraf

    In the present work dry polysaccharides were extracted from two traditional plants, fenugreek (Trigonella Foenum graecum) and tamarind (Tamarindus indica). Both extracted polysaccharide were subjected for several parameter to find out their suitability used as pharmaceutical excipients. Polysaccharides were evaluated for their physicochemical parameters which revealed an acceptable range of micrometric properties. Mean value of total percentage glucose concentration in fenugreek and tamarind was calculated 23.5±4.72 and 31.9±6.32 respectively. Molecular weight of fenugreek and tamarind was estimated by refractive index method which found to be 2.03x10−6 and 1.79 x 106 kg/kg mol respectively. Rheological study indicates that aqueous solution of both polysaccharide possessed non-newtonian pseudoplastic flow behavior. Finally, cell viability assay confirm that both polysaccharide may be considered as safe excipients during drug delivery. The study confirmed that both plat polysaccharides (Trigonella foenum graecum) and (Tamarindus indica) can be considered as effective pharmaceutical excipients for the preparation of novel drug delivery systems.


  • Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design

    by Parameswara Rao Vuddanda, Amit Mishra, Sanjay Kumar Singh

    The intention of this study is to achieve higher entrapment efficiency (EE) of berberine chloride (selected hydrophilic drug) using nanoprecipitation technique. The solubility of drug was studied in various pH buffers (1.2-7.2) for selection of aqueous phase and stabilizer. Quality by design (QbD)-based 3(2) factorial design were employed for optimization of formulation variables; drug to polymer ratio (X1) and surfactant concentration (X2) on entrapment efficiency (EE), particle size (PS) and polydispersity index (PDI) of the nanoparticles. The nanoparticles were subjected to solid state analysis, in vitro drug release and stability study. The aqueous phase and stabilizer selected for the formulations were pH 4.5 phthalate buffer and surfactant F-68, respectively. The formulation (F-6) containing drug to polymer ratio (1:3) and stabilizer (F-68) concentration of 50 mM exhibited best EE (82.12%), PS (196.71 nm), PDI (0.153). The various solid state characterizations assured that entrapped drug is amorphous and nanoparticles are fairly spherical in shape. In vitro drug release of the F-6 exhibited sustained release with non-Fickian diffusion and stable at storage condition. This work illustrates that the proper selection of aqueous phase and optimization of formulation variables could be helpful in improving the EE of hydrophilic drugs by nanoprecipitation technique.


  • Open Access

    Intestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies

    by Amit Mishra, Parameswara Rao Vuddanda, Sanjay Singh

    The aim of the present work was to design and develop Praziquantal (PZQ) loaded solid lipid nanoparticles (PZQ-SLN) to improve the oral bioavailability by targeting intestinal lymphatic system. PZQ is practically insoluble in water and exhibits extensive hepatic first-pass metabolism. PZQ SLN were composed of triglycerides, lecithin and various aqueous surfactants; were optimized using hot homogenization followed by ultrasonication method. The optimized SLN had particle size of123±3.41 nm, EE of86.6±5.72%. The drug release of PZQ-SLN showed initial burst release followed by the sustained release. Inspite of zeta potential being around −10 mV, the optimized SLN were stable at storage conditions (5±3°C and25±2°C/60±5% RH) for six months. TEM study confirmed the almost spherical shape similar to the control formulations. Solid state characterization using differential scanning calorimeter (DSC) and powder X-ray diffraction (PXRD) analysis confirmed the homogeneous distribution of PZQ within the lipid matrix. The 5.81-fold increase inAUC0→∞, after intraduodenal administration of PZQ-SLN in rats treated with saline in comparison to rats treated with cycloheximide (a blocker of intestinal lymphatic pathway), confirmed its intestinal lymphatic delivery. The experimental results indicate that SLN may offer a promising strategy for improving the therapeutic efficacy and reducing the dose.


  • Effect of Lipid Matrix on repaglinide-loaded Solid Lipid Nanoparticles for Oral Delivery

    by Manoj K Rawat, Achint Jain, Amit Mishra, Madaswamy S Muthu, Sanjay Singh

    Aim: To study the effect of different types of lipid on the entrapment efficiency (EE) and physical stability of repaglinide (RG)-loaded solid lipid nanoparticles (SLNs). RG-loaded SLNs were prepar...


  • Development of Repaglinide Loaded Solid Lipid Nanocarrier: Selection of Fabrication Method

    by M. K. Rawat, A. Jain, A. Mishra, M. S. Muthu, S. Singh

    Repaglinide solid lipid nanoparticles (RG-SLN) were fabricated using stearic acid as lipid. Pluronic F68 (PLF68) and soya lecithin were used as a stabilizer. SLNs were prepared by modified solvent injection and ultrasonication methods. SLNs prepared with modified solvent injection method have larger particle size (360±2.5nm) than prepared with ultrasonication method (281± 5.3nm). The zeta potential of the prepared formulations by these two methods varied from - 23.10 ± 1.23 to -26.01 ± 0.89 mV. The maximum entrapment efficiency (62.14 ± 1.29%) was obtained in modified solvent injection method. The total drug content was nearly same (98% ) in both the methods. In vitro release studies were performed in phosphate buffer (pH 6.8) with 0.5% sodium lauryl sulphate (SLS) using dialysis bag diffusion technique. The cumulative drug release was 30% and 50% within 2 hrs in modified solvent injection and ultrasonication method, respectively. This indicates that RG-SLN prepared from modified injection method released the drug more slowly than SLNs prepared with ultrasonication method. Differential scanning calorimetry indicates that repaglinide (RG) entrapped in the solid lipid nanoparticles (SLN) exist in an amorphous or molecular state. Repaglinide loaded solid lipid nanoparticles prepared with both methods were of spherical shape as observed by transmission electron microscopy (TEM). These results suggest that modified solvent injection method is more suitable for preparation of repaglinide SLNs using stearic acid.